Oncogenic ALK regulates EMT in non-small cell lung carcinoma through repression of the epithelial splicing regulatory protein 1Claudia Voena(Harvard University), Roberto Chiarle(Boston Children's Hospital)OncotargetApril 23, 201610.18632/oncotarget.8955Cited by 45SaveCiteExport RISWatch citationsRelated PapersNPM-ALK transgenic mice spontaneously develop T-cell lymphomas and plasma cell tumors|Blood|2003|247Phosphatidylinositol 3-kinase δ blockade increases genomic instability in B cells|Nature|2017|123Tumor Resistance against ALK Targeted Therapy-Where It Comes From and Where It Goes|Cancers|2018|97Tyrosine phosphatases regulate resistance to ALK inhibitors in ALK+ anaplastic large cell lymphoma|Blood|2021|48Excess of NPM-ALK oncogenic signaling promotes cellular apoptosis and drug dependency|Oncogene|2015|44